CH618431A5 - - Google Patents

Download PDF

Info

Publication number
CH618431A5
CH618431A5 CH1634376A CH1634376A CH618431A5 CH 618431 A5 CH618431 A5 CH 618431A5 CH 1634376 A CH1634376 A CH 1634376A CH 1634376 A CH1634376 A CH 1634376A CH 618431 A5 CH618431 A5 CH 618431A5
Authority
CH
Switzerland
Prior art keywords
group
compound
carbostyril
formula
hydroxy
Prior art date
Application number
CH1634376A
Other languages
English (en)
French (fr)
Inventor
Kazuyuki Nakagawa
Eiyu Yo
Shiro Yoshizaki
Shigeharu Tamada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CH618431A5 publication Critical patent/CH618431A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/32—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1634376A 1976-10-08 1976-12-27 CH618431A5 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51121423A JPS609713B2 (ja) 1976-10-08 1976-10-08 カルボスチリル誘導体

Publications (1)

Publication Number Publication Date
CH618431A5 true CH618431A5 (sv) 1980-07-31

Family

ID=14810767

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1634376A CH618431A5 (sv) 1976-10-08 1976-12-27

Country Status (10)

Country Link
US (1) US4223137A (sv)
JP (1) JPS609713B2 (sv)
BE (1) BE849794A (sv)
CA (1) CA1074801A (sv)
CH (1) CH618431A5 (sv)
DE (1) DE2658544C2 (sv)
FR (1) FR2378521A1 (sv)
GB (1) GB1540628A (sv)
NL (1) NL174041C (sv)
SE (1) SE434395B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
US4322425A (en) * 1980-03-14 1982-03-30 Otsuka Pharmaceutical Co., Ltd. Compositions for treating glaucoma
FI77852C (sv) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Förfarande för framställning av nya, såsom hjärtmediciner användbara s ubstituerade amid- och (mättad heterocykel)karbonylkarbostyrilderivat.
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
ATE27451T1 (de) * 1981-03-24 1987-06-15 Ciba Geigy Ag Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS60173736U (ja) * 1984-04-25 1985-11-18 株式会社昭和製作所 緩衝器用サブタンク
JPS61191767A (ja) * 1985-02-20 1986-08-26 辻本　夘太郎 植物張り家屋
JPS62113672A (ja) * 1985-11-12 1987-05-25 本田技研工業株式会社 リヤクツシヨン用リザ−ブタンク
JPS6348401U (sv) * 1986-09-17 1988-04-01
US4687776A (en) * 1986-10-24 1987-08-18 Warner-Lambert Company Drug stabilization
JPS63106132A (ja) * 1986-10-24 1988-05-11 Mazda Motor Corp 車両のサスペンシヨン装置
JPS6374545U (sv) * 1986-10-31 1988-05-18
JPH0517463Y2 (sv) * 1987-07-21 1993-05-11
JPS6417047U (sv) * 1987-07-21 1989-01-27
JPH0518510Y2 (sv) * 1987-12-28 1993-05-17
US4894219A (en) * 1988-03-29 1990-01-16 University Of Florida Beta-agonist carbostyril derivatives, assay method and pharmacological composition
JPH026831U (sv) * 1988-06-28 1990-01-17
US20030229058A1 (en) 2001-11-13 2003-12-11 Moran Edmund J. Aryl aniline beta2 adrenergic receptor agonists
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (en) 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
WO2003099764A1 (en) 2002-05-28 2003-12-04 Theravance, Inc. ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
EP1565472A2 (en) * 2002-11-27 2005-08-24 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
TW200526547A (en) 2003-09-22 2005-08-16 Theravance Inc Amino-substituted ethylamino β2 adrenergic receptor agonists
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
FR2869893B1 (fr) * 2004-05-06 2006-07-28 Rhodia Chimie Sa Nouveaux granules de phosphates de calcium de type hydroxyapatite, leur procede de preparation et leurs applications
US7307076B2 (en) 2004-05-13 2007-12-11 Boehringer Ingelheim International Gmbh Beta agonists for the treatment of respiratory diseases
WO2005110990A1 (de) * 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
US20080039495A1 (en) 2004-06-03 2008-02-14 Linsell Martin S Diamine Beta2 Adrenergic Receptor Agonists
WO2006031556A2 (en) 2004-09-10 2006-03-23 Theravance. Inc. Amidine substituted aryl aniline compounds
GB0624757D0 (en) * 2006-12-12 2007-01-17 Sosei R & D Ltd Novel compounds
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975391A (en) * 1973-12-26 1976-08-17 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
JPS539227B2 (sv) * 1973-12-26 1978-04-04
US4026897A (en) * 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat

Also Published As

Publication number Publication date
FR2378521A1 (fr) 1978-08-25
DE2658544C2 (de) 1985-10-03
JPS609713B2 (ja) 1985-03-12
US4223137A (en) 1980-09-16
SE434395B (sv) 1984-07-23
DE2658544A1 (de) 1978-04-13
CA1074801A (en) 1980-04-01
NL7614329A (nl) 1978-04-11
NL174041B (nl) 1983-11-16
JPS5346983A (en) 1978-04-27
FR2378521B1 (sv) 1979-06-29
BE849794A (fr) 1977-04-15
SE7614539L (sv) 1978-04-09
NL174041C (nl) 1984-04-16
GB1540628A (en) 1979-02-14
AU2085576A (en) 1978-04-06

Similar Documents

Publication Publication Date Title
CH618431A5 (sv)
CH653021A5 (fr) Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
EP0031753B1 (fr) Nouveaux dérivés de la (pipéridyl-4)-2 (quinolyl-4)-1 éthanone, produits intermédiaires et procédés pour leur préparation, et leur utilisation comme médicaments
EP0053964B1 (fr) Médicaments à base de dérivés de (quinolyl-4)-1 éthanol ou propanol, nouveaux dérivés de (quinolyl-4)-1 éthanol ou propanol et procédés pour leur préparation
EP0089894B1 (fr) (Benzimidazolyl-1)-1,N-((hydroxy-4 méthoxy-3 phényl)-2 hydroxy-2 éthyl) amino-3 butane et ses sels et hydrates à activité bêta-adrénergique, leurs applications thérapeutiques, et procédé pour les préparer
EP0028959B1 (fr) Dérivés de la 5,8,13,13a-tétrahydro-6H-dibenzo (a,g) quinolizine, procédé d'obtention et compositions pharmaceutiques les contenant
CH630629A5 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament.
CH619453A5 (sv)
EP0173585B1 (fr) Médicaments à base de dérivés de la pipéridine, nouveaux dérivés de la pipéridine et leurs procédés de préparation
JPH0578554B2 (sv)
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
US3091638A (en) N, n'-disubstituted hydrazine derivatives
FR3067711A1 (fr) Inhibiteurs de la catechol-o-methyl-transferase (comt)
WO2001044197A2 (fr) Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses
BE852556A (fr) Derives de carbostyrile et leur procede de preparation
FR2522663A1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
CH616156A5 (sv)
CA1217724A (fr) Compositions pharmaceutiques utiles comme antiarythmiques
KR800000542B1 (ko) 아미노-페닐-에탄올아민의 제조방법
EP0155888A1 (fr) Dérivés de (quinol yl-4)-1 (piperidyl-4)-2 ethanamine et de (quinolyl-4)-1 (piperidyl-4)-3 propanamine, procédés pour leur préparation et médicaments les contenant
CH638210A5 (fr) Ester derive de l'acide quinolopyranne-4-one-2-carboxylique, procede de sa preparation et utilisation de cet ester comme compose actif dans un medicament antiallergique pour le traitement de l'asthme.
EP2938595B1 (fr) Procede de synthese d'une hydrazine utile dans le traitement du virus du papillome
CA1116089A (fr) Compositions pharmaceutiques comprenant des medicaments a base de derives de la quinoleine
EP0078735B1 (fr) Nouveaux dérivés appartenant à la famille des 3-amino-1-hétéroaryloxy-2-propanols, utilisation en thérapeutique et procédé de préparation
KR850000031B1 (ko) 사이클로알카[4,5]피롤로[2,3-g]-이소퀴놀린의 제조방법

Legal Events

Date Code Title Description
PL Patent ceased